Fourth-Quarter Highlights Orders of $2.0 billion , up 42% on a reported basis and 10% organically Revenue of $2.1 billion , up 41% on a reported basis and 9% organically Earnings per share of $1.10 , up 34%; $0.99 on an adjusted basis, down 1% Full-Year Highlights Revenue of $7.4 billion , up 33% Read more
Danaher Launches Collaboration with Cincinnati Children’s Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development Danaher Beacon for Preclinical Drug Safety seeks to address major cause of failure in clinical trials Program will leverage automated liver organoid technology for drug toxicity screening Aims to expand genetic diversity of screening, accelerate therapy development,... Read more
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024 Enables the Simultaneous Measurement of 64 Molecular Interactions BOSTON–(BUSINESS WIRE)– At the SLAS2024 International Conference and Exhibition, Bruker Corporation (Nasdaq: BRKR) today introduced the ground-breaking, new ‘Triceratops’ SPR #64 Surface Plasmon Resonance (SPR) instrument. The SPR #64 system... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023 Highlights Fourth quarter revenue was $10.89 billion, 5% lower versus the same quarter last year. Core organic revenue... Read more
ANDOVER, Mass., Jan. 30, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (Nasdaq: MKSI), a global provider of technologies that transform our world, was recognized for outstanding production support by Taiwan Semiconductor Manufacturing Company (TSMC) at their Supply Chain Management Forum. “We are Read more
WASHINGTON, Jan. 30, 2024 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2023. All results in this release reflect only continuing operations unless otherwise noted. Key Fourth Quarter 2023 Results Net earnings were $1.1 billion, or $1.50 per diluted common share and non-GAAP adjusted diluted... Read more
ANDOVER, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) — MKS Instruments, a global provider of technologies that transform our world, was recently selected as a recipient of the 2024 Campus Forward Award , presented by recruitment automation platform RippleMatch. Read more
Chemspeed Accelerates Bruker’s Laboratory Automation and Digitalization Drive BASEL, Switzerland–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced a definitive agreement for the acquisition of Chemspeed Technologies AG, aSwiss provider of vendor-agnostic automated laboratory R&D and QC workflow solutions. Chemspeed is focused on modular automation and robotics solutions for chemical research, pharma drug formulation, materials research... Read more
MKS’ market-leading brands – Newport™, Ophir®, and Spectra-Physics® – continue commitment to innovation with new products ANDOVER, Mass., Jan. 24, 2024 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that transform our world, is committed to developing, Read more
The new CRO facility for proteomics services in Newton, Massachusetts ensures closer proximity to US customers Biognosys’ center of excellence for proteomics innovation at its headquarters near Zurich, Switzerland continues to offer its entire portfolio of services for discovery, targeted, and structural proteomics for all regions, including the Americas ZURICH & NEWTON, Massachusetts–(BUSINESS WIRE)– Biognosys,... Read more